Pmcs-002
Research payments
$2,843,510
Through program year 2025, $2,843,510 in research payments was reported against Pmcs-002, across 462 payments, paid by RxSight Inc.
- Paid by
- RxSight Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $330,000 | 67 |
| 2024 | Research | $1,247,380 | 214 |
| 2023 | Research | $1,266,130 | 181 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Sheri Rowen Newport Beach, CA Named on 17 payments
- Thomas Newsom Tampa, FL Named on 16 payments
- Gregg Feinerman Newport Beach, CA Named on 14 payments
- Mitchell Shultz Northridge, CA Named on 12 payments
- Inder Singh Racine, WI Named on 11 payments
- Jeffrey Whitman Dallas, TX Named on 10 payments
- Centrael Evans Athens, GA Named on 10 payments
- Anh Nguyen Falls Church, VA Named on 9 payments
- Jeffrey Boyd Newark, DE Named on 9 payments
- Dan Tran Long Beach, CA Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.